entertainment -WSS

entertainment

author：comprehensive 2025-08-19 09:17:24 - browse：92418

Senate Health, Education, Labor, and Pensions Committee Chairman Bernie Sanders looks at Moderna CEO Stephane Bancel as he testifies. Sitting next to Sanders, ranking member Sen. Bill Cassidy looks down – policy coverage from STAT — Committee Ranking Republican Bill Cassidy (La.) and Chairman Bernie Sanders (I-Vt.) Chip Somodevilla/Getty Images

WASHINGTON – The Senate health committee on Thursday passed a package of bills aimed at speeding generic drug competition and reining in drug middlemen business practices. But they failed to pass an ambitious reform to the pharmacy benefit manager sector, despite strong bipartisan support for it.

Chairman Bernie Sanders (I-Vt.) is pursuing the drug pricing reforms at the behest of Senate Majority Leader Chuck Schumer (D-N.Y.), who wants to hold a floor vote on an even bigger package of health bills later this year. The markup came just a day after the same panel held a major hearing on PBM and drugmakers’ role in high insulin prices.

It’s not clear when the Senate would take up that package, and while the package is bipartisan, it’s not clear whether it has enough support among House Republicans to pass in that chamber. There are a few, tamer PBM bills that the House Energy and Commerce Committee is expected to mark up May 17, but there is no indication that Senate and House lawmakers are coordinating on PBM legislation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

WSS

Health AI: on the border between health care and tech

Montana youths win climate lawsuit against state for promoting fossil fuels

After Optum profits sink, UnitedHealth makes changes

Treatments for cramps don't cut it. Why aren't there better options?

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

SAMSHA loosens regulations on methadone treatment centers

knowledge

entertainment

leisure time

Cancer drug shortages should be causing more outrage

Indictment alleges Trump's ex

After affirmative action ruling, medical educators look to 'holistic review'

Quicker fix for pulse oximeters urged during FDA public meeting

Apple is now the first public company to be valued at $3 trillion

Illumina slashes 2023 revenue projections yet again

The high cost of giving birth even with insurance

New Ultima Genomics DNA sequencer can read genome for $100

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Hospitals are dialing back on venture capital investing

explore

BMS, looking to build heart drug business, turns to AI for diagnosis

Apple Vision Pro: A first look at health apps on the new VR headset

Mark Cuban is blaming the wrong people for high drug costs

Cybersecurity threat forces Lurie Children's to take systems offline

Some dementia cases could be undiagnosed liver disease

Dozens dead from Maui wildfires: What we know about the victims

hotspot

knowledge

entertainment

leisure time